Kashaf Waqar, Zainab A. The tale and trials of Efgartigimod: a newly FDA approved drug for the treatment of Myasthenia gravis. J Pak Med Assoc [Internet]. 2022 Oct. 15 [cited 2026 Jul. 27];72(11):2366-7. Available from: https://www.jpma.org.pk/index.php/public_html/article/view/6388